Yunling Yi

（Dalian medical university. No.9 West of Lvshun Southern Road, Dalian City, Liaoning Province, China. 116044.）

Abstract:BACKGROUND: The BMJ reported a finding in a nationwide cohort study at last year. It pointed that compare with the reduction in risk of cancer seen after HSIL management; management of AGC seems to have been suboptimal in preventing cervical cancer. There were no reports of therapeutic intervention at home and abroad. AIM: To introduce an effective treatment to patients with AGC in Thin-Cytologic Test.  METHODS: Reviewing the past treatment. A patient with AGC in TCT refused further pathological examination. She had black hypomenorrhea, dysmenorrheal and other dis-comfortable. To acupuncture Tianshu, Zigong, Guanyuan, Zusanli, Sanyinjiao, Yanglingquan, with a far-infra red lamp irradiate her belly. Rechecking Thin-Cytologic Test (TCT) after the 3rd amenstrual cycle. RESULT: AGC disappeared after the 2nd amenstrual cycle. The dis-comfortable  disappeared too. Another patient with atypical squamous cell and high-risk human papilloma virus (HPV) positive, had been punctured for two amenstrual cycles. Her TCT returned to normal too. CONCLUSIONS: Acupuncture may be a good choice for patients with AGC and atypical squamous cell in Thin-Cytologic Test. Therefore, it is a possible choice for other cervical precancerous lesions. Acupuncture for the patients with this disease is importance for the early prevention of cervical cancer, and it is worth to clinical application.

KEY WORDS: Atypical glandular cells, Acupuncture, Cervical, Adenocarcinoma